Carcinoma in situ bladder is a high grade and ag-gressive manifestation of transitional cell carcinoma of bladder that has highly variable course. The purpose of this study is to analyse how this serious disease is dealt with, most effective treatment option available and its clinical progression inspite of intervention. All patients diagnosed to have CIS bladder histolo-gically in Harrogate District Hospital from August 94 to August 99 were included in the study. All data con-cerning the management, treatment and subsequent fol-low-up were collected from the patients′ records and analysed in a systematic way. A total of 20 patients were included in the study. Analysis showed that there was no age or sex predilection and the age group range...
Objective: The aim of this study was to evaluate the use of intravesical treatment and cancer-specif...
The authors report their experience in the treatment of 21 patients with carcinoma situ of the bladd...
Contains fulltext : 79753.pdf (publisher's version ) (Closed access)Urothelial car...
Contains fulltext : 57580.pdf (publisher's version ) (Closed access)Carcinoma is s...
Urothelial carcinoma in situ (CIS) is regarded as a precursor of invasive bladder carcinoma. Althoug...
Urothelial carcinoma in situ (CIS) is regarded as a precursor of invasive bladder carcinoma. Althoug...
Item does not contain fulltextCONTEXT: Urothelial carcinoma in situ (CIS) has a high propensity for ...
CONTEXT: Urothelial carcinoma in situ (CIS) has a high propensity for progression. It is usually rep...
CONTEXT: Urothelial carcinoma in situ (CIS) has a high propensity for progression. It is usually rep...
Management of carcinoma in situ of the bladder remains a complex and challenging endeavor due to its...
Urothelial carcinoma of the bladder is diagnosed predominantly in people over 60 years of age. The m...
Clinical course and histological findings of 692 patients with bladder tumor were reviewed to reveal...
BACKGROUND: To identify the predictive factors for progression defined as any event that shifted the...
The bladder is a hollow organ in the lower part of the abdomen. It is shaped like a small balloon an...
Objective: The aim of this study was to evaluate the use of intravesical treatment and cancer-specif...
Objective: The aim of this study was to evaluate the use of intravesical treatment and cancer-specif...
The authors report their experience in the treatment of 21 patients with carcinoma situ of the bladd...
Contains fulltext : 79753.pdf (publisher's version ) (Closed access)Urothelial car...
Contains fulltext : 57580.pdf (publisher's version ) (Closed access)Carcinoma is s...
Urothelial carcinoma in situ (CIS) is regarded as a precursor of invasive bladder carcinoma. Althoug...
Urothelial carcinoma in situ (CIS) is regarded as a precursor of invasive bladder carcinoma. Althoug...
Item does not contain fulltextCONTEXT: Urothelial carcinoma in situ (CIS) has a high propensity for ...
CONTEXT: Urothelial carcinoma in situ (CIS) has a high propensity for progression. It is usually rep...
CONTEXT: Urothelial carcinoma in situ (CIS) has a high propensity for progression. It is usually rep...
Management of carcinoma in situ of the bladder remains a complex and challenging endeavor due to its...
Urothelial carcinoma of the bladder is diagnosed predominantly in people over 60 years of age. The m...
Clinical course and histological findings of 692 patients with bladder tumor were reviewed to reveal...
BACKGROUND: To identify the predictive factors for progression defined as any event that shifted the...
The bladder is a hollow organ in the lower part of the abdomen. It is shaped like a small balloon an...
Objective: The aim of this study was to evaluate the use of intravesical treatment and cancer-specif...
Objective: The aim of this study was to evaluate the use of intravesical treatment and cancer-specif...
The authors report their experience in the treatment of 21 patients with carcinoma situ of the bladd...
Contains fulltext : 79753.pdf (publisher's version ) (Closed access)Urothelial car...